Supply of Vecuronium Bromide (Pharmaceuticals)

The contract requires the manufacture and supply of Vecuronium Bromide, identified by NSN 6505-01-258-0983, under strict regulatory and logistical standards mandated by the Department of Defense. Compliance with FDA regulations is essential, along with adherence to DLA packaging specifications and MMS NO. 1 labeling requirements to ensure uniformity and safety across military medical supply chains. The product must maintain a non-extendable 24-month shelf life from the date of manufacture, with no allowances for extension, emphasizing the importance of precise production timing and inventory management. The solicitation is classified as a subcontract under NAICS code 325412, indicating the pharmaceutical manufacturing nature of the work, and is issued by the Medical Supply Chain Pharm FSA within the Department of Defense. The response deadline is May 15, 2026, with the solicitation posted on May 12, 2026, providing a narrow window for submission and requiring prompt and accurate proposal development to meet all technical, regulatory, and compliance criteria.